VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), a leading
provider of premium cannabis products and services for the medical and
adult-use markets and holder of licenses under the Cannabis Act through its
wholly-owned subsidiaries, Canna Farms Limited, Abcann Medicinals Inc. and
Harvest Medicine Inc., this morning announced the release of its Q4 and 2018
annual financial and operating results. “The VIVO team achieved significant
milestones in 2018, leading to substantial increases in net revenue, cash
position, production capacity, organizational effectiveness and customer
development,” VIVO CEO Barry Fishman said in the news release. “The strategic
acquisitions of Canna Farms and Harvest Medicine were important drivers of our
improved financial results. Through the acquisition of Canna Farms, we have
added an award-winning BC craft brand, are leveraging best practices, and have
dramatically increased capacity. Harvest Medicine provides a scalable network
of medical cannabis clinics offering industry-leading patient care and access
to critical data to shape our innovative product development efforts. VIVO
remains committed to changing the way people view cannabis and to ensuring
medical patients and adult-use consumers have access to our premium cannabis
products and services.”
To view the full press release, visit http://ibn.fm/iSdn6
About VIVO Cannabis(TM)
VIVO Cannabis(TM), based in Napanee, Ontario, is recognized
for trusted, high-quality products and services. It holds production and sales
licenses from Health Canada and operates world-class indoor cultivation
facilities with proprietary plant-growing technology. VIVO has a collection of
premium brands targeting unique customer segments, including Beacon
Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO
acquired Canna Farms, a premium cannabis company based in Hope, British
Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years
of craft cultivation experience and expertise, as well as a significant patient
base and positive cash flow. The Company is significantly expanding its production
capacity and pursuing partnership and product development opportunities
domestically, as well as in select international markets, including Germany and
Australia. VIVO also operates Harvest Medicine, a patient-centric and highly
scalable network of specialty medical cannabis clinics as well as a free
telemedicine app. VIVO has a healthy balance sheet and is well-positioned to
accelerate its growth in Canada and internationally. For more information,
visit the company’s website at www.VivoCannabis.com.
NOTE TO INVESTORS: The latest news and updates
relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF
About MissionIRNewsBreaks
MissionIRNewsBreaks provide
a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by
our Team of professional journalists that keep a constant eye on the markets,
these posts are designed to inform you on the latest happenings of our clients
and other publicly traded companies on our radar. From earnings, acquisitions
and agreements to conference attendance and clinical study results, our news
breaks keep you up-to-date with the day’s top movers. MissionIR is primarily
focused on strategic communications. We have executed countless communications
programs to address the needs of companies ranging from start-ups to
established industry leaders, gaining valuable experience and the expertise
necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
